ethyl gallate has been researched along with Infections, Pseudomonas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, ZQ; Gotes, J; Jacobs, H; Kasian, K; Mink, SN | 1 |
| Alston, TA; Wang, J | 1 |
2 other study(ies) available for ethyl gallate and Infections, Pseudomonas
| Article | Year |
|---|---|
Benefits of ethyl gallate versus norepinephrine in the treatment of cardiovascular collapse in Pseudomonas aeruginosa septic shock in dogs.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Gallic Acid; Norepinephrine; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Risk Assessment; Shock, Cardiogenic; Shock, Septic; Survival Rate; Treatment Outcome | 2012 |
Gallic treatment is galling to Pseudomonas.
Topics: Animals; Gallic Acid; Norepinephrine; Pseudomonas aeruginosa; Pseudomonas Infections; Shock, Cardiogenic; Shock, Septic | 2012 |